AngioDynamics: A Surgical Approach To Market Growth
AngioDynamics' NanoKnife FDA clearance boosts its potential in cancer treatment. Read why ANGO stock is a buy with its growth ...
Moody National Bank Trust Division Buys 23,003 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)
Moody National Bank Trust Division increased its position in AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) by 70.2% in the ...
What To Expect From AngioDynamics Inc (ANGO) Q2 2025 Earnings
AngioDynamics Inc (NASDAQ:ANGO) is set to release its Q2 2025 earnings on Jan 8, 2025. The consensus estimate for Q2 2025 ...
AngioDynamics Inc (ANGO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
AngioDynamics Inc (ANGO) reports a robust 9% revenue growth, driven by MedTech and mechanical thrombectomy segments, while ...
AngioDynamics Publishes APEX-AV Trial Results In JSCAI
AngioDynamics, Inc. (ANGO), a New York-based medical technology company Monday announced the publication of results from the Acute ...
AngioDynamics (NASDAQ:ANGO) Price Target Raised to $15.00
AngioDynamics (NASDAQ:ANGO – Free Report) had its price objective increased by HC Wainwright from $14.00 to $15.00 in a research note released on Friday,Benzinga reports. They currently have a buy ...
AngioDynamics, Inc. (ANGO) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Conference Call January 8, 2025 8:00 AM ETCompany ParticipantsJim Clemmer - President and Chief ...
AngioDynamics announces publication of APEX-AV trial results in JSCAI
AngioDynamics (ANGO) announced the publication of the results from the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System or ...